Evidence map›Paper›PMID 40636864›Full record

ArticleFrontiers in public health2025

Co-design of the Australian Prompt Response Network for a public-health focused intersectoral approach to information sharing on emerging drugs of concern.

Krista J Siefried, Penny Hill, Brendan Clifford, Jared Brown, Andrew Camilleri, Sione Crawford, Paul Dessauer, Ella Dilkes-Frayne, Jack Freestone, John Gobeil and 12 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Krista J SiefriedThe National Centre for Clinical Research on Emerging Drugs, The University of New South Wales, Sydney, NSW, Australia.
Penny HillThe National Centre for Clinical Research on Emerging Drugs, The University of New South Wales, Sydney, NSW, Australia.
Brendan CliffordThe National Centre for Clinical Research on Emerging Drugs, The University of New South Wales, Sydney, NSW, Australia.
Jared BrownCentre for Alcohol and Other Drugs, New South Wales Ministry of Health, St Leonards, NSW, Australia.
Andrew CamilleriForensic Science SA, Adelaide, SA, Australia.
Sione CrawfordHarm Reduction Victoria, Melbourne, VIC, Australia.
Paul DessauerPeer Based Harm Reduction WA, Perth, WA, Australia.
Ella Dilkes-FraynePopulation Health Division, ACT Health Directorate, Canberra, ACT, Australia.
Jack FreestoneThe National Centre for Clinical Research on Emerging Drugs, The University of New South Wales, Sydney, NSW, Australia.
John GobeilAustralian Injecting and Illicit Drug Users League (AIVL), Sydney, NSW, Australia.
Mary E HarrodThe NSW Users and AIDS Association (NUAA), Sydney, NSW, Australia.
Suzie HudsonThe National Drug and Alcohol Research Centre, the University of New South Wales, Randwick, NSW, Australia.
Philip HullPopulation Health Division, ACT Health Directorate, Canberra, ACT, Australia.
Simon LentonNational Drug Research Institute and enAble Institute, Curtin University, Perth, WA, Australia.
Tom LyonsVictorian Department of Health, Melbourne, VIC, Australia.
Grace OhAustralian Drug Education & Consultancy, Bellevue, WA, Australia.
Amy PeacockThe National Drug and Alcohol Research Centre, the University of New South Wales, Randwick, NSW, Australia.
Alice PierceThe NSW Users and AIDS Association (NUAA), Sydney, NSW, Australia.
Peter SidawayNorthern Territory AIDS and Hepatitis Council (NTAHC), Darwin, NT, Australia.
Jessamine SoderstromEmergency Medicine, Royal Perth Hospital, Perth, WA, Australia.
Stephanie TzanetisPill Testing Australia, Canberra, ACT, Australia.
Nadine EzardThe National Centre for Clinical Research on Emerging Drugs, The University of New South Wales, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid emergence of new psychoactive substances (NPS) and other emerging drugs of concern presents a significant global public health challenge, necessitating agile and interconnected drug information systems to identify and communicate risks. In Australia, responses have traditionally been localized, lacking a nationally coordinated system to rapidly share information about emerging drug threats. The National Center for Clinical Research on Emerging Drugs (NCCRED) collaborated with jurisdictional networks, clinicians, scientists, policy-makers, and peer organizations to co-design and co-produce the national Prompt Response Network ("PRN"). This process identified key components necessary to create an effective health-focused national network that supports and enhances existing and emerging jurisdictional and specialist early warning networks. The co-creation process resulted in several outputs, including a formalized national PRN group, an online knowledge exchange platform, a national website for disseminating drug alerts, and identified needs for a national drug signal database and an anecdotal reporting system. The PRN is the first Australian national public-health-focused mechanism for information exchange on new and emerging drugs and drug trends of concern. It provides the means for timely and responsive sharing of localized data, better informing risk assessment and facilitating a coordinated approach to public health responses and local and national preparation for emerging risks. Achieving this required mobilizing diverse disciplinary and community stakeholders toward a unified and collaborative response to preventing drug related harms.

Indexed as

Information DisseminationIntersectoral CollaborationPublic HealthSubstance-Related DisordersAustraliaHumansco-creationco-designcounterfeit pharmaceuticalsdrug risk communicationearly warning systememerging drugsnew psychoactive substances (NPS)

Identifiers

PMID40636864
PMCPMC12237992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.